Bio-Techne (TECH) Other Non-Current Liabilities (2014 - 2026)
Bio-Techne's (TECH) quarterly Other Non-Current Liabilities came in at $21.7 million in Q1 2026, up 38.4% year-on-year from $15.7 million in Q1 2025, and down 6.11% quarter-over-quarter from $23.1 million in Q4 2025.
Bio-Techne (TECH) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Bio-Techne's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $21.7 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 38.4% year-over-year to $21.7 million in Q1 2026; TTM through Mar 2026 was $21.7 million, a 38.4% increase from a year earlier, with the FY2025 full-year figure at $27.1 million, up 105.84% from the prior year.
- Other Non-Current Liabilities eased to $21.7 million in Q1 2026 per TECH's latest filing, from $23.1 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $27.1 million in Q2 2025 and bottomed at $5.0 million in Q2 2022.
- The 5-year median for Other Non-Current Liabilities is $12.8 million (2022), against an average of $15.1 million.
- Across the five-year window, Other Non-Current Liabilities plunged 72.68% in 2022 and jumped 118.38% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $11.3 million in 2022, then surged by 53.15% to $17.4 million in 2023, then sank by 34.7% to $11.3 million in 2024, then surged by 103.56% to $23.1 million in 2025, then dropped by 6.11% to $21.7 million in 2026.
- Per Business Quant, the three latest TECH Other Non-Current Liabilities figures stand at $21.7 million (Q1 2026), $23.1 million (Q4 2025), and $23.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.67 Mn |
| Dec 31, 2025 | 23.08 Mn |
| Sep 30, 2025 | 23.81 Mn |
| Jun 30, 2025 | 27.08 Mn |
| Mar 31, 2025 | 15.66 Mn |
| Dec 31, 2024 | 11.34 Mn |
| Sep 30, 2024 | 19.79 Mn |
| Jun 30, 2024 | 13.16 Mn |
| Mar 31, 2024 | 11.56 Mn |
| Dec 31, 2023 | 17.36 Mn |
| Sep 30, 2023 | 9.39 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 10.97 Mn |
| Dec 31, 2022 | 11.34 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 12.77 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 17.60 Mn |
| Jun 30, 2021 | 18.30 Mn |